[go: up one dir, main page]

CA2702623A1 - Utilisation de la tenascine w en tant que biomarqueur pour le cancer du colon - Google Patents

Utilisation de la tenascine w en tant que biomarqueur pour le cancer du colon Download PDF

Info

Publication number
CA2702623A1
CA2702623A1 CA2702623A CA2702623A CA2702623A1 CA 2702623 A1 CA2702623 A1 CA 2702623A1 CA 2702623 A CA2702623 A CA 2702623A CA 2702623 A CA2702623 A CA 2702623A CA 2702623 A1 CA2702623 A1 CA 2702623A1
Authority
CA
Canada
Prior art keywords
tenascin
serum
concentration
cancer
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2702623A
Other languages
English (en)
Inventor
Ruth Chiquet-Ehrismann
Martin Degen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2702623A1 publication Critical patent/CA2702623A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
CA2702623A 2007-10-22 2008-10-21 Utilisation de la tenascine w en tant que biomarqueur pour le cancer du colon Abandoned CA2702623A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07118948 2007-10-22
EP07118948.4 2007-10-22
PCT/EP2008/064199 WO2009053354A1 (fr) 2007-10-22 2008-10-21 Utilisation de la ténascine w en tant que biomarqueur pour le cancer du côlon

Publications (1)

Publication Number Publication Date
CA2702623A1 true CA2702623A1 (fr) 2009-04-30

Family

ID=38884682

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2702623A Abandoned CA2702623A1 (fr) 2007-10-22 2008-10-21 Utilisation de la tenascine w en tant que biomarqueur pour le cancer du colon

Country Status (5)

Country Link
EP (1) EP2205977A1 (fr)
JP (1) JP2011501147A (fr)
CN (1) CN101836115A (fr)
CA (1) CA2702623A1 (fr)
WO (1) WO2009053354A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102507925B (zh) * 2011-11-30 2013-10-30 尉军 一种改良的人血中抗体的检测方法
BR112014014295A2 (pt) * 2011-12-12 2017-06-13 Isis Innovation método para determinar um estado de artrite reumatoide, kit para a determinação o estado de artrite reumatoide erosiva de um indivíduo, usos de tenancina-c, e de uma determinação do nível de tenascina-c, e, métodos para tratar uma condição inflamatória, e uma artrite reumatoide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0207224D0 (en) * 2002-03-27 2002-05-08 Novartis Forschungsstiftung Tenascin-W compositions and uses thereof

Also Published As

Publication number Publication date
WO2009053354A1 (fr) 2009-04-30
JP2011501147A (ja) 2011-01-06
EP2205977A1 (fr) 2010-07-14
CN101836115A (zh) 2010-09-15

Similar Documents

Publication Publication Date Title
JP5711196B2 (ja) 卵巣癌を判定するためのｈｅ４及び他の生化学マーカーの使用
Bianco et al. Identification of cripto-1 as a novel serologic marker for breast and colon cancer
ES2637411T3 (es) Métodos y ensayos para medir p95 Y/O p95 en una muestra y anticuerpos específicos para p95
Degen et al. Tenascin‐W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients
KR101147586B1 (ko) 결장직장암에 대한 마커로서 단백질 ｓ100ａ12 의 용도
EP2962113B1 (fr) Anticorps anti-p40, systèmes et procédés
Ghods et al. High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma
US9562906B2 (en) Methods for detection of gastric cancer
CN105658810A (zh) 用于检测前列腺癌的方法
JP2020060585A (ja) 診断用の細胞表面前立腺癌抗原
JP2012524521A (ja) グリコデリンモノクローナル抗体および卵巣癌の検出におけるその使用のための方法
KR20050114604A (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
WO2022083603A1 (fr) Utilisation d'un complexe d'inhibiteur de cystéine protéase et de cathepsine en tant que marqueur de diagnostic de tumeur
CN102803968B (zh) 食道癌标志物
EP2494361B2 (fr) Marqueurs de tumeurs des ovaires et leurs méthodes d'utilisation
CN109975549A (zh) 肿瘤来源IgG在胰腺癌诊断或预后中的用途
Berndt et al. Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder
CN103429617B (zh) 包含抗-ck8/18复合物自身抗体的标记物及其诊断癌症的用途
CA2702623A1 (fr) Utilisation de la tenascine w en tant que biomarqueur pour le cancer du colon
JP2014115186A (ja) 胃癌、肺癌及び／又は食道癌の検出方法
JP2006526149A (ja) 乳癌に対するマーカーとしてのタンパク質細胞性レチノイン酸結合タンパク質ｉｉ（ｃｒａｂｐｉｉ）の使用
US20150004621A1 (en) Biological marker for early cancer detection and methods for cancer detection (bf819)
US20130095483A1 (en) Predictive biomarkers for breast cancer
EP2650307A1 (fr) PROCÉDÉ DE MESURE IMMUNOLOGIQUE DE LA PROTÉINE cofiline-1
EP4141445A1 (fr) Antigène du cancer pour la détection précoce du cancer

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20141021